Outcomes
death
DISEASE PROGRESSION
The dual primary endpoints were PFS (time from randomization to first disease progression or death) assessed by the IRRC in accordance with RECIST v1.1 and OS (time from randomization to death due to any cause). Secondary endpoints included IRRC-assessed PFS using iRECIST